(Q41579973)

4 October 2017

1 reference

title

Iodinated contrast material in uroradiology. Choice of agent and management of complications (English)

1 reference

4 October 2017

Cohan RH

1

1 reference

4 October 2017

Ellis JH

series ordinal

2

1 reference

4 October 2017

publication date

1 August 1997

1 reference

Urologic Clinics of North America

4 October 2017

published in

1 reference

4 October 2017

volume

24

1 reference

4 October 2017

issue

3

1 reference

4 October 2017

page(s)

471-491

1 reference

The current status of reactions to intravenous contrast media

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Metformin-induced lactic acidosis in the presence of acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

1 reference

7 January 2021

Contrast material for combined abdominal and pelvic CT: can cost be reduced by increasing the concentration and decreasing the volume?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Comparison of iohexol 300 and diatrizoate meglumine 60 for body CT: image quality, adverse reactions, and aborted/repeated examinations

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Comparative randomized double-blind study of hydroxyzine versus placebo as premedication before injection of iodinated contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Effects of iopamidol on neonatal thyroid function

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Cost-effective use of low-osmolality contrast media for CT of the liver: evaluation of liver enhancement provided by various doses of iohexol

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Informed consent for contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Treatment of adverse contrast media reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Contrast media reactions: experimental evidence against the allergy theory

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Delayed reactions to contrast media after interleukin-2 immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Evaluation of lopamidol and diatrizoate in excretory urography: a double-blind clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Treatment of reactions to radiographic contrast material

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Use of low-osmolar agents and premedication to reduce the frequency of adverse reactions to radiographic contrast media: a survey of the Society of Uroradiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Resorption of contrast material from the bladder during cystourethrography causing an excretory urogram

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Fatal reactions to intravenous nonionic contrast material

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

New contraindication to intravascular iodinated contrast material

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Anaphylactoid reactions during voiding cystourethrography

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Fetal uptake of an intravascular radiologic contrast medium

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Selective use of low-osmolar contrast media.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Radiocontrast nephrotoxicity. A review.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Injection rate: a factor in contrast reactions?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Low dose low osmolar intravenous urography

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Atypical contrast reactions associated with systemic interleukin-2 therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Comparison of the side-effects of low-osmolar contrast media in intravenous urography

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Anaphylactic/anaphylactoid reaction to contrast dye administered in the ureter.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Diagnostic efficacy of excretory urography with low-dose, nonionic contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Contrast media reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

The prevention of immediate generalized reactions to radiocontrast media in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Administration of radiographic contrast media in high-risk patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Two pretreatment regimens for high-risk patients receiving radiographic contrast media.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Prophylaxis against repeated radiocontrast media reactions in 857 cases. Adverse experience with cimetidine and safety of beta-adrenergic antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Current usage of nonionic contrast

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Patient choice and nonionic contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Selective use of low-osmolality contrast agents for i.v. urography and CT: safety and effect on cost.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Iodinated contrast media-induced nephropathy: pathophysiology, clinical aspects and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Nonionic versus ionic contrast media in intravenous urography: clinical trial in 1,000 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Adverse reactions to urographic contrast medium. Rapid versus slow injection rate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Reactions to contrast material during retrograde pyelography

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Nephrotoxicity from contrast media: attenuation with theophylline

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Results of randomized controlled trials of low-versus high-osmolality contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

A coherent biochemical basis for increased reactivity to contrast material in allergic patients: a novel concept.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Etiology of anaphylactoid responses. The promise of nonionics

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Pretreatment with corticosteroids to prevent reactions to i.v. contrast material: overview and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Radiocontrast-associated renal dysfunction: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Cost containment in the use of low-osmolar contrast agents: effect of guidelines, monitoring, and feedback mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Clinical intravenous urography: comparative trial of ioxaglate and iopamidol

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Corticosteroid pretreatment for potential contrast reactions in children with lymphoreticular cancer: a word of caution

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Complications associated with cystography in children

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Multiple myeloma and contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

A large trial of intravenous Conray 325 and Niopam 300 to assess immediate and delayed reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Extravasation injury with nonionic contrast material

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Systemic reaction to contrast media during cystography

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Toxicological safety assessment of iomeprol, a new X-ray contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Cimetidine (Tagamet) combined with steroids and H1 antihistamines for the prevention of serious radiographic contrast material reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Mutagenic evaluation of radiographic contrast media.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Contrast-enhanced CT of the liver and spleen: comparison of ionic and nonionic contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Bosentan, an orally active endothelin antagonist: effect on the renal response to contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

The RACR survey of intravenous contrast media reactions. Final report

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Delayed reactions to urographic contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

A fatal reaction following injection of urographic medium: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Skin ulceration from extravasation of low-osmolality contrast medium: a complication of automation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Contrast-associated nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Experimental contrast-associated nephropathy and its clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Prevention of anaphylactoid reactions after radiographic contrast media infusion by combined histamine H1- and H2-receptor antagonists: results of a prospective controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Adverse effect of amniofetography on fetal thyroid function

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Respiratory (cardiac) arrest after retrograde pyelography with neomycin-containing medium

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Adverse reactions to intravascularly administered contrast media. A comprehensive study based on a prospective survey

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Contrast media adverse reactions: occurrence, recurrence, and distribution patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Comparison of iohexol-240 versus iohexol-300 in abdominal CT

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

New and old contrast agents: pharmacology, tissue opacification, and excretory urography

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

High-dose clinical urography with the low-osmolality contrast agent Hexabrix: comparison with a conventional contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Renal streak artifact during contrast-enhanced CT: comparison of low versus high osmolality contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Risks for renal dysfunction with cardiac angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Contrast-induced nephrotoxicity in patients undergoing cardiac catheterization

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Life-threatening hypotensive reactions to contrast media administration: comparison of pharmacologic and fluid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Contrast media reactions during voiding cystourethrography or retrograde pyelography

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Risk of radiocontrast nephropathy in patients with and without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

High- and low-osmolar contrast agents in urography: a comparison of the appearances with respect to pyelotubular opacification and renal length

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Iohexol for excretory urography: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: comparison of adverse effects

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Late adverse reactions to nonionic contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Injury due to extravasation of nonionic contrast material

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

Increased incidence of hypersensitivity to iodine-containing radiographic contrast media after interleukin-2 administration

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970397-9

7 January 2021

10.1016/S0094-0143(05)70397-9

Identifiers

DOI

1 reference

4 October 2017

1 reference